Parvovirus 4 Infection and Clinical Outcome in High-Risk Populations

Ruth Simmons, Colin Sharp, C. Patrick McClure, Janine Rohrbach, Helen Kovari, Eleni Frangou, Peter Simmonds, William L. Irving, Andri Rauch, Paul Bowness,

The Journal of Infectious Diseases · 2012 · 34 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the correlations with disease status. We found that PARV4 infection frequently occurred in individuals exposed to bloodborne viruses (95% in HCV-HIV coinfected intravenous drug users [IDUs]). There were no correlations between PARV4 serostatus and HCV outcomes. There was, however, a significant association with early HIV-related symptoms, although because this was tightly linked to both HCV status and clinical group (IDU), the specific role of PARV4 is not yet clear.

References

13